LYVANTA Trademark

Trademark Overview


On Tuesday, November 11, 2025, a trademark application was filed for LYVANTA with the United States Patent and Trademark Office. The USPTO has given the LYVANTA trademark a serial number of 79439722. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, June 9, 2026. This trademark is owned by U-Ploid Biotechnologies Ltd. The LYVANTA trademark is filed in the Pharmaceutical Products category with the following description:

Fertility-enhancing drugs; pharmaceuticals and medical preparations, namely, fertility-enhancing drugs, ovulation stimulants, and hormonal therapies; pharmaceutical and medical preparations for fertility treatments, namely, fertility-enhancing drugs, ovulation stimulants, and hormonal therapies; ovulation stimulants, namely, pharmaceutical preparations for stimulating ovulation; pharmaceutical drugs that stimulate ovulation to aid in conception; dietary supplements for reproductive health; diagnostic reagents for medical use; dietary supplements to support implantation; hormonal therapies being pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and support of hormonal disorders; In vitro fertilization (IVF) diagnostic preparations for medical purposes; cell cryopreservation solutions for medical purposes, namely, solutions for medical and clinical use in storing and treating cells, blood, and blood components; semen analysis kits for medical purposes; en...
lyvanta

General Information


Serial Number79439722
Word MarkLYVANTA
Filing DateTuesday, November 11, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, June 9, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesFertility-enhancing drugs; pharmaceuticals and medical preparations, namely, fertility-enhancing drugs, ovulation stimulants, and hormonal therapies; pharmaceutical and medical preparations for fertility treatments, namely, fertility-enhancing drugs, ovulation stimulants, and hormonal therapies; ovulation stimulants, namely, pharmaceutical preparations for stimulating ovulation; pharmaceutical drugs that stimulate ovulation to aid in conception; dietary supplements for reproductive health; diagnostic reagents for medical use; dietary supplements to support implantation; hormonal therapies being pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and support of hormonal disorders; In vitro fertilization (IVF) diagnostic preparations for medical purposes; cell cryopreservation solutions for medical purposes, namely, solutions for medical and clinical use in storing and treating cells, blood, and blood components; semen analysis kits for medical purposes; endometrial receptivity tests for medical purposes; luteal phase support in the form of dietary supplement; tests to measure ovarian reserve and predict response to fertility treatments for medical use; tests to evaluate ovarian function and fertility potential for medical use; nutrient solutions for medical and clinical use to support the growth of embryos in the lab

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 18, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameU-Ploid Biotechnologies Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, December 18, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, December 29, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 29, 2025APPLICATION FILING RECEIPT MAILED
Friday, March 20, 2026ASSIGNED TO EXAMINER
Monday, March 23, 2026NON-FINAL ACTION WRITTEN
Tuesday, March 24, 2026NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, May 1, 2026REFUSAL PROCESSED BY MPU
Friday, May 1, 2026NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, May 21, 2026REFUSAL PROCESSED BY IB
Tuesday, June 9, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 9, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 9, 2026TEAS/EMAIL CORRESPONDENCE ENTERED